Economic impact of contrast stress echocardiography on the diagnosis and initial treatment of patients with suspected coronary artery disease

Journal of the American Society of Echocardiography

Volumn 15, Issue 11, 2002, Pages 1335-1345

  Tardif, Jean Claude ^a   Dore, Annie ^a   Chan, Kwan L ^b   Fagan, Sue ^b   Honos, Georges ^c   Marcotte, François ^c   Yu, Eric ^d   Siu, Samuel ^d   Dumesnil, Jean ^e   Arsenault, Marie ^e   Koilpillai, Chris ^f   D'Onofrio, Franco ^g  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^g INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIPYRIDAMOLE; DOBUTAMINE; LEVOVIX; SHU 508; CARDIOTONIC AGENT; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; STRESS ECHOCARDIOGRAPHY; ULTRASOUND; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; COST BENEFIT ANALYSIS; ECONOMICS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CARDIOTONIC AGENTS; CONTRAST MEDIA; CORONARY ARTERIOSCLEROSIS; COST-BENEFIT ANALYSIS; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036827118     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1067/mje.2002.125287     Document Type: Article

References (22)

1. Chan B, Coyte P, Heick C. Economic impact of cardiovascular disease in Canada. Can J Cardiol 1996;12:1000-6.
2. O'Keefe JH Jr, Barnhart CS, Bateman TM. Comparison of stress echocardiography and stress myocardial perfusion scintigraphy for diagnosing coronary artery disease and assessing its severity. Am J Cardiol 1995;75:25-34D.
3. Nihoyannopoulos P. Two-dimensional stress echocardiography in coronary artery disease. Curr Opin Cardiol 1996;11:403-8.
4. Bonow RO. Diagnosis and risk stratification in coronary artery disease: nuclear cardiology versus stress echocardiography J Nucl Cardiol 1997;4:S172-8.
5. Marwick T, D'Hondt A-M, Baudhuin T, Willemart B, Wijns W, Detry JM, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, of both? J Am Coll Cardiol 1993;22:159-67.
6. Galanti G, Sciagra R, Comeglio M, Taddei T, Bonechi F, Giusti F, et al. Diagnostic accuracy of peak exercise echocardiography in coronary artery disease: comparison with thallium-201 myocardial scintigraphy. Am Heart J 1991;122:1609-15.
7. Patterson RE, Horowitz SF, Eisner RL. Comparison of modalities to diagnose coronary artery disease. Semin Nucl Med 1994;24:286-310.
8. Fleischmann KE, Hunink MGM, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? JAMA 1998;280:913-20.
9. Laurienzo JM. Detection of coronary artery disease in women. Crit Care Nursing Clin North Am 1997;9:469-75.
10. Tong AT, Douglas PS. Stress echocardiography in women. Stress Echo 1999;17:573-82.
11. Sieswerda GTJ, Kamp O, Visser CA. Myocardial contrast echocardiography: clinical benefit and practical issues. Echocardiography 2000;17:S25-36.
12. Fritzch T, Schlief R. SHU508A. Drugs Future 1995;20:1224-7.
13. Schroder K, Agrawal R, Voller H, Schlief R, Schroder R. Improvement of endocardial border delineation in suboptimal stress-echocardiograms using the new left heart contrast agent SHU 508A. Int J Card Imaging 1994;10:45-51.
14. Iliceto S, Ciati C, Aragona P, Verde R, Schlief R, Rizzon P. Improved Doppler signal intensity in coronary arteries after intravenous peripheral injection of a lung-crossing contrast agent (SHU 508A). J Am Coll Cardiol 1994;23:184-90.
15. von Bibra H, Sutherland G, Becher H, Neudert J, Nihoyannopoulos P. Clinical evaluation of left heart Doppler contrast enhancement by a saccharide-based transpulmonary contrast agent. J Am Coll Cardiol 1995;25:500-8.
16. Firschke C, Koberl B, von Bibra H, Horcher J, Schomig A. Combined use of contrast-enhanced 2-dimension and color Doppler echocardiography for improved left ventricular endocardial border delineation using Levovist, a new venous echocardiographic contrast agent. Int J Card Imaging 1997;13:137-44.
17. Kuntz KM, Fleischmann KE, Hunink MGM, Douglas PS. Cost-effectiveness of diagnostic strategies for patients with chest pain. Ann Intern Med 1999;130:709-18.
18. Marwick TH, Anderson T, Williams MJ, Haluska B, Melin JA, Pashkow F, et al. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 1995;26:335-41.
19. Kim C, Kwok YS, Saha S, Redberg RF. Diagnosis of suspected coronary artery disease in women: a cost-effectiveness analysis. Am Heart J 1999;137:1019-34.
20. Shaw LJ. Impact of contrast echocardiography on diagnostic algorithms: pharmaco-economic implications. Clin Cardiol 1997;20:139-48.
21. Shaw LJ, Monaghan MJ, Niyannopolous P. Clinical and economic outcomes assessment with myocardial contrast echocardiography. Heart 1999;82:6-21.
22. Shaw LJ, Heller GV, Travin MI, Lauer M, Marwick T, Hachamovitch R, et al. Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain: Economics of Noninvasive Diagnosis (END) Study Group. J Nucl Cardiol 1999;6:559-69.